Review of migraine incidence and management in obstetrics and gynaecology
- PMID: 31336231
- DOI: 10.1016/j.ejogrb.2019.07.021
Review of migraine incidence and management in obstetrics and gynaecology
Abstract
Purpose: Migraines are the third most prevalent disorder, and seventh-highest specific cause of disability worldwide. Migraines have a multitude of underlying aetiologies; the pathology may come as a result of hormonal treatment or as a sole symptom during menstrual cycle or pregnancy, with variable intensity and duration. In addition, clinicians should be fully aware of the potential complications and well-versed in management options.
Methods: A systematic review of the incidence, symptoms, treatment options and complications among women suffering from migraines in gynaecology, as well as obstetrical cases has been performed. The significance of migraines as a marker in antenatal care and contraception treatment has also been investigated.
Results: The incidence of migraines in gynaecological and obstetrical cases, and contraceptive users were 11.7-12.5 %, 9-38.5 %, and 16.7-54.7% respectively. There is an average six-fold increase in the risk of stroke in women who take combined hormonal contraception and suffer from migraines. Four papers with 1565 patients proposed the combination of triptans along with the progesterone only pill. Desogestrel 75mcg/day was found to reduce the intensity of migraines compared to the combined hormonal contraceptives. The risk of gestational hypertension, pre-eclampsia, low birth weight, and preterm birth was found to be increased in pregnant women suffering from migraines.
Conclusion: Migraines have a high incidence in gynaecology and obstetrics. Health care providers must include screening questions when history taking to identify women with migraines and effectively manage them. Proper follow-up and treatment is required for all women with migraines in order to minimize the risk of cerebrovascular events, and negative pregnancy outcomes. Women with migraines are advised to avoid combined hormonal contraception and use progesterone only pills.
Keywords: COCP; Headache; Management; Migraine; Pregnancy.
Copyright © 2019 Elsevier B.V. All rights reserved.
Similar articles
-
Headaches and migraines are associated with an increased risk of preeclampsia in Peruvian women.Am J Hypertens. 2008 Mar;21(3):360-4. doi: 10.1038/ajh.2007.46. Epub 2008 Jan 17. Am J Hypertens. 2008. PMID: 18202669
-
Adolescent Pregnancy Guidelines.J Obstet Gynaecol Can. 2015 Aug;37(8):740-756. doi: 10.1016/S1701-2163(15)30180-8. J Obstet Gynaecol Can. 2015. PMID: 26474231
-
Migraine management in pregnancy.Clin Exp Obstet Gynecol. 2016;43(5):661-665. Clin Exp Obstet Gynecol. 2016. PMID: 30074315 Review.
-
Temporal relations in hormone-withdrawal migraines and impact on prevention- a diary-based pilot study in combined hormonal contraceptive users.J Headache Pain. 2017 Aug 25;18(1):91. doi: 10.1186/s10194-017-0801-7. J Headache Pain. 2017. PMID: 28842849 Free PMC article.
-
Exploring the Connection between Migraines and Pregnancy: The Impact of Physical Activity on Symptom Management.Medicina (Kaunas). 2023 Dec 27;60(1):49. doi: 10.3390/medicina60010049. Medicina (Kaunas). 2023. PMID: 38256310 Free PMC article. Review.
Cited by
-
Pre-pregnancy migraine diagnosis, medication use, and spontaneous abortion: a prospective cohort study.J Headache Pain. 2022 Dec 20;23(1):162. doi: 10.1186/s10194-022-01533-6. J Headache Pain. 2022. PMID: 36539705 Free PMC article.
-
De novo Migraine with Aura in the Third Trimester of Pregnancy: A Case Report and Literature review.Acta Med Litu. 2021;28(1):145-152. doi: 10.15388/Amed.2021.28.1.19. Epub 2021 May 11. Acta Med Litu. 2021. PMID: 34393637 Free PMC article.
-
POTS and Pregnancy: A Review of Literature and Recommendations for Evaluation and Treatment.Int J Womens Health. 2022 Dec 24;14:1831-1847. doi: 10.2147/IJWH.S366667. eCollection 2022. Int J Womens Health. 2022. PMID: 36590760 Free PMC article. Review.
-
Bibliometric Analysis of Research on Migraine-Stroke Association from 2013 to 2023.J Pain Res. 2023 Dec 1;16:4089-4112. doi: 10.2147/JPR.S438745. eCollection 2023. J Pain Res. 2023. PMID: 38058980 Free PMC article.
-
Shared Molecular Genetic Mechanisms Underlie Endometriosis and Migraine Comorbidity.Genes (Basel). 2020 Feb 29;11(3):268. doi: 10.3390/genes11030268. Genes (Basel). 2020. PMID: 32121467 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical